Adaptimmune To Participate In The Guggenheim Securities SMID Cap Biotech Conference February 6, 2025
(MENAFN- Newsfile Corp) Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - January 30, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to redefine the treatment of solid tumor cancers with cell therapy, today …